BioSpace News Archive

Bayer will present new research from the Company’s oncology portfolio, including Stivarga® (regorafenib) and Vitrakvi® (larotrectinib), at the 2020 American Society of Clinical Oncology Gastrointestinal (ASCO GI) Cancers Symposium, taking place January 23-25 in San Francisco, California.

Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced it has entered into a definitive agreement with two institutional investors for the purchase and sale of 10,000,000 shares of the Company’s common stock

BDC Advisors, a healthcare strategy consulting firm, today announced the appointment of Pam Nicholson, a nationally recognized healthcare strategist and executive, as a Director and a leader of BDC’s Health Enterprise Strategy consulting practice

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its fourth quarter and full year 2019 financial results on Thursday, February 6, 2020 after the close of financial markets.

Rite Aid Corporation announced the early results of its previously announced offer to exchange up to $600 million aggregate principal amount of its outstanding 6.125% Senior Notes due 2023 for newly issued 7.500% Senior Secured Notes due 2025, upon the terms and subject to the conditions set forth in the offering memorandum dated January 6, 2020.

SHINE Medical Technologies LLC, the Institute of Organic Chemistry and Biochemistry (IOCB Prague) and GE Healthcare today announced the production of patient dose quantities of the therapeutic isotope lutetium-177 (Lu-177).

OncoHost, global leader in host response profiling for improved personalized cancer therapy, together with its partner RayBiotech, a leading life sciences company developing high-throughput protein detection technologies for biomarker discovery initiatives, announced today the companies have been awarded a $1 million grant from the Israel-U.S

BioNovelus, Inc. (OTC: ONOV) announces that Austin Branch has joined the Company’s Advisory Board. BioNovelus’ Advisory Board seats individual, entrepreneurs, senior information technology (IT), cybersecurity, Information Warfare (IW), Electronic Warfare (EW), and government technology executives with business and technical expertise useful for assisting in identifying, integrating and growing acquired companies.

Inotrem S.A. announced that it has entered a worldwide licensing agreement with Roche Diagnostics for the commercialization of a mechanism-based companion diagnostic test using a soluble plasma protein.

PhoreMost’s next-generation phenotypic screening platform, SITESEEKER, to identify novel targets for Otsuka’s therapeutics discovery programmes